Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Kelman JA"'
Autor:
Menis, M, Siwakoti, S, Wan, Z, Hu, M, Barney, S, Chillarige, Y, Kelman, JA, Forshee, RA, Whitaker, BI
Publikováno v:
In Value in Health June 2024 27(6) Supplement:S168-S168
Autor:
Menis, M, Izurieta, HS, Kessler, Z, Kim, B, McKean, S, Warnock, R, Verma, S, Phua, Y, Yi, A, Kelman, JA, Anderson, SA, Forshee, RA
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S148-S148
Autor:
Menis, M, Izurieta, HS, Lu, Y, McKean, S, Kim, B, Kessler, Z, Warnock, R, Verma, S, Phua, Y, Kelman, JA, Anderson, SA, Forshee, RA
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S55-S55
Autor:
Menis M, Anderson SA, Izurieta HS, Kumar S, Burwen DR, Gibbs J, Kropp G, Erten T, Macurdy TE, Worrall CM, Kelman JA, Walderhaug MO, Menis, Mikhail, Anderson, Steven A, Izurieta, Hector S, Kumar, Sanjai, Burwen, Dale R, Gibbs, Jonathan, Kropp, Garner, Erten, Tugce
Publikováno v:
Emerging Infectious Diseases; Jan2012, Vol. 18 Issue 1, p128-131, 4p
Autor:
Pennap D; Formerly with the US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring MD., Mosholder AD; US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring MD. Electronic address: andrew.mosholder@fda.hhs.gov., Ajao A; US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring MD., Boley E; US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring MD., Dharmarajan S; Formerly with the US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring MD., Akhtar S; Acumen LLC, Burlingame, CA., Naik KB; Acumen LLC, Burlingame, CA., Flowers N; Acumen LLC, Burlingame, CA., Wernecke M; Acumen LLC, Burlingame, CA., MaCurdy TE; Acumen LLC, Burlingame, CA; Department of Economics, Stanford University, Stanford, CA., Kelman JA; Centers for Medicare & Medicaid Services, Washington DC., Graham DJ; US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring MD.
Publikováno v:
Urology [Urology] 2024 Oct; Vol. 192, pp. 111-118. Date of Electronic Publication: 2024 Jun 15.
Autor:
Kural KC; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.; School of Systems Biology, George Mason University, Manassas, VA 20110, United States., Mazo I; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States., Walderhaug M; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States., Santana-Quintero L; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States., Karagiannis K; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States., Thompson EE; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States., Kelman JA; Centers for Medicare & Medicaid Services, Washington, DC 20001, United States., Goud R; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.
Publikováno v:
JAMIA open [JAMIA Open] 2024 Jun 21; Vol. 7 (2), pp. ooae037. Date of Electronic Publication: 2024 Jun 21 (Print Publication: 2024).
Autor:
Perez-Vilar S; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Freyria Duenas P; Acumen LLC, Burlingame, California., Radin R; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Akhtar S; Acumen LLC, Burlingame, California., Wernecke M; Acumen LLC, Burlingame, California., Kelman JA; Centers for Medicare & Medicaid Services, Washington, DC., Graham DJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2417634. Date of Electronic Publication: 2024 Jun 03.
Autor:
Shi XC; Acumen LLC, Burlingame, CA, USA. Electronic address: xshi@acumenllc.com., Gruber JF; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Joann.Gruber@fda.hhs.gov., Ondari M; Acumen LLC, Burlingame, CA, USA. Electronic address: mondari@acumenllc.com., Lloyd PC; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Patricia.Lloyd@fda.hhs.gov., Freyria Duenas P; Acumen LLC, Burlingame, CA, USA. Electronic address: pduenas@acumenllc.com., Clarke TC; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Tainya.Clarke@fda.hhs.gov., Nadimpalli G; Acumen LLC, Burlingame, CA, USA. Electronic address: gnadimpalli@acumenllc.com., Cho S; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Sylvia.Cho@fda.hhs.gov., Feinberg L; Acumen LLC, Burlingame, CA, USA. Electronic address: lfeinberg@acumenllc.com., Hu M; Acumen LLC, Burlingame, CA, USA. Electronic address: mhu@acumenllc.com., Chillarige Y; Acumen LLC, Burlingame, CA, USA. Electronic address: ychillarige@acumenllc.com., Kelman JA; Centers for Medicare & Medicaid Services, Washington, DC, USA. Electronic address: Jeffrey.Kelman@cms.hhs.gov., Forshee RA; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Richard.Forshee@fda.hhs.gov., Anderson SA; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Steven.Anderson@fda.hhs.gov., Shoaibi A; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Azadeh.Shoaibi@fda.hhs.gov.
Publikováno v:
Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3486-3492. Date of Electronic Publication: 2024 May 03.
Autor:
Lloyd PC; US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: patricia.lloyd@fda.hhs.gov., Lufkin B; Acumen LLC, Burlingame, CA, USA., Moll K; IBM Consulting, Bethesda, MD, USA., Ogilvie RP; Optum Epidemiology, Boston, MA, USA., McMahill-Walraven CN; CVS Health, Blue Bell, PA, USA., Beachler DC; Carelon Research, Wilmington, DE, USA., Kelman JA; Centers for Medicare & Medicaid Services, Baltimore, MD, USA., Shi X; Acumen LLC, Burlingame, CA, USA., Hobbi S; IBM Consulting, Bethesda, MD, USA., Amend KL; Optum Epidemiology, Boston, MA, USA., Djibo DA; CVS Health, Blue Bell, PA, USA., Shangguan S; Acumen LLC, Burlingame, CA, USA., Shoaibi A; US Food and Drug Administration, Silver Spring, MD, USA., Sheng M; IBM Consulting, Bethesda, MD, USA., Secora A; IQVIA, Falls Church, VA, USA., Zhou CK; US Food and Drug Administration, Silver Spring, MD, USA., Kowarski L; IBM Consulting, Bethesda, MD, USA., Chillarige Y; Acumen LLC, Burlingame, CA, USA., Forshee RA; US Food and Drug Administration, Silver Spring, MD, USA., Anderson SA; US Food and Drug Administration, Silver Spring, MD, USA., Muthuri S; IBM Consulting, Bethesda, MD, USA., Seeger JD; Optum Epidemiology, Boston, MA, USA., Kline A; CVS Health, Blue Bell, PA, USA., Reich C; IQVIA, Falls Church, VA, USA., MaCurdy T; Acumen LLC, Burlingame, CA, USA; Department of Economics, Stanford University, Stanford, CA, USA., Wong HL; US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Mar 19; Vol. 42 (8), pp. 2004-2010. Date of Electronic Publication: 2024 Feb 22.
Autor:
Lu Y; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Matuska K; Acumen LLC, Burlingame, California., Nadimpalli G; Acumen LLC, Burlingame, California., Ma Y; Acumen LLC, Burlingame, California., Duma N; Acumen LLC, Burlingame, California., Zhang HT; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Chiang Y; Acumen LLC, Burlingame, California., Lyu H; Acumen LLC, Burlingame, California., Chillarige Y; Acumen LLC, Burlingame, California., Kelman JA; US Centers for Medicare & Medicaid Services, Washington, DC., Forshee RA; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Anderson SA; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA [JAMA] 2024 Mar 19; Vol. 331 (11), pp. 938-950.